These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15734145)

  • 1. Role of SOCS2 in growth hormone actions.
    Turnley AM
    Trends Endocrinol Metab; 2005 Mar; 16(2):53-8. PubMed ID: 15734145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone and SOCS2 regulation of neuronal differentiation: possible role in mental function.
    Turnley AM
    Pediatr Endocrinol Rev; 2005 Mar; 2(3):366-71. PubMed ID: 16429112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knock your SOCS off!
    Leroith D; Nissley P
    J Clin Invest; 2005 Feb; 115(2):233-6. PubMed ID: 15690080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling.
    Turnley AM; Faux CH; Rietze RL; Coonan JR; Bartlett PF
    Nat Neurosci; 2002 Nov; 5(11):1155-62. PubMed ID: 12368809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness.
    Ransome MI; Goldshmit Y; Bartlett PF; Waters MJ; Turnley AM
    Eur J Neurosci; 2004 Apr; 19(8):2069-79. PubMed ID: 15090034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
    Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
    Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Socs2 expression causes the high-growth phenotype in mice.
    Horvat S; Medrano JF
    Genomics; 2001 Mar; 72(2):209-12. PubMed ID: 11401434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of neuronal subpopulations in mice over-expressing suppressor of cytokine signaling-2.
    Ransome MI; Turnley AM
    Neuroscience; 2005; 132(3):673-87. PubMed ID: 15837129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of SOCS2 on neuronal differentiation and morphology.
    Scott HJ; Stebbing MJ; Walters CE; McLenachan S; Ransome MI; Nichols NR; Turnley AM
    Brain Res; 2006 Jan; 1067(1):138-45. PubMed ID: 16360125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions.
    Rico-Bautista E; Flores-Morales A; Fernández-Pérez L
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):431-9. PubMed ID: 17070092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOCS2 induces neurite outgrowth by regulation of epidermal growth factor receptor activation.
    Goldshmit Y; Walters CE; Scott HJ; Greenhalgh CJ; Turnley AM
    J Biol Chem; 2004 Apr; 279(16):16349-55. PubMed ID: 14764607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOCS2 negatively regulates growth hormone action in vitro and in vivo.
    Greenhalgh CJ; Rico-Bautista E; Lorentzon M; Thaus AL; Morgan PO; Willson TA; Zervoudakis P; Metcalf D; Street I; Nicola NA; Nash AD; Fabri LJ; Norstedt G; Ohlsson C; Flores-Morales A; Alexander WS; Hilton DJ
    J Clin Invest; 2005 Feb; 115(2):397-406. PubMed ID: 15690087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells.
    Fruchtman S; Simmons JG; Michaylira CZ; Miller ME; Greenhalgh CJ; Ney DM; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G342-50. PubMed ID: 15831713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic STAT proteins: regulation of somatostatin neurones by growth hormone via STAT5b.
    Bennett E; McGuinness L; Gevers EF; Thomas GB; Robinson IC; Davey HW; Luckman SM
    J Neuroendocrinol; 2005 Mar; 17(3):186-94. PubMed ID: 15796771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
    Michaylira CZ; Simmons JG; Ramocki NM; Scull BP; McNaughton KK; Fuller CR; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G472-81. PubMed ID: 16574995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
    Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
    Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphogens in motion: growth control of the neural tube.
    Cayuso J; Martí E
    J Neurobiol; 2005 Sep; 64(4):376-87. PubMed ID: 16041754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Growth hormone signaling pathways].
    Zych S; Szatkowska I; Czerniawska-Piatkowska E
    Postepy Biochem; 2006; 52(4):367-72. PubMed ID: 17536505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between growth hormone and insulin signaling.
    Xu J; Messina JL
    Vitam Horm; 2009; 80():125-53. PubMed ID: 19251037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling mechanisms mediating local GH action in the neural retina of the chick embryo.
    Sanders EJ; Baudet ML; Parker E; Harvey S
    Gen Comp Endocrinol; 2009 Sep; 163(1-2):63-9. PubMed ID: 19344664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.